ERA PerMed Cluster event on Personalised Medicine with ITN funded projects Maria Cristina Nieto Garcia - European Commission
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
ERA PerMed
Cluster event on Personalised Medicine with ITN funded projects
Maria Cristina Nieto Garcia
National Institute of Health Carlos III (ISCIII), ERA PerMed coordinator
National Health School, ISCIII, Madrid, Spain, 6-7th Nov 2019
Horizon 2020 GRANT AGREEMENT
NUMBER — 779282 ERA PerMed
ERAPerMed – Content ERA PerMed JTC2018 (co-funded by EC) JTC2019 Next calls: JTC2020 & JTC2021
ERAPerMed – Characteristics
19 EU countries
3 associated countries (to Horizon 2020)
Turkey, Norway, Israel
1 third country (Canada)
32 Partners 5 regions; Saxony, Quebec,
23 Countries Lombardy, Navarra and Cataluña
Coordination: The biggest ERA Net in health
Instituto de Salud Carlos III
(ISCIII), SPAIN TIME FRAME: 1 December 2017 – 30 November 2022
Joint Transnational Calls (JTCs)
1 EU Co-funded Call 2018
MAIN OBJECTIVES
Up to 3 Additional Calls 2019, 2020, 2021
http://www.erapermed.eu/
Action Plan SRIA
Horizon 2020
Call: H2020-SC1-2016-2017 https://www.
(Personalised Medicine) icpermed.eu/
Topic: SC1-HCO-03-2017
Foster the implementation of ICPerMed Action Plan and SRIA
(Strategic Research and Innovation Agenda) by funding transnational
research projects in the field of Personalised Medicine (PM)
Alignment of regional and national PM research strategies and
funding activities, promoting excellence, reinforcing the
competitiveness of Europe and Canada and enhance the European
collaboration as well as with countries beyond the European Union.
ERAPerMed Definition of Personalised Medicine: Stated in the Strategic Research and Innovation Agenda (SRIA) of PerMed, adopted from the H2020 advisory group*: • “Personalised Medicine refers to a medical model using characterisation of individuals’ phenotypes and genotypes (e.g. molecular profiling, medical imaging, lifestyle data) for tailoring the right therapeutic strategy for the right person at the right time, and/or to determine the predisposition to disease and/or to deliver timely and targeted prevention.” * European Commission. Advice for 2016/2017 of the Horizon 2020 Advisory Group for Social Challenge 1, “Health, Demographic Change and Wellbeing
ERAPerMed – Structure
WP1 - COORDINATION & MANAGEMENT
EC cofunded call WP6 - ADDITIONAL
WP2+WP3+WP4+WP5 NON COFUNDED CALLS
WP 7 - STRATEGIC SUPPORT ACTIVITIES
External relationships, relationship with end users and patient
representatives, sustainability and exploitation of results…ERAPerMed – Structure
EC cofunded call
WP 2 - PREPARATION AND LAUNCH OF
THE EU CO-FUNDED CALL
WP 3 – EVALUATION & PROPOSAL
SELECTION OF THE EU CO-FUNDED CALL
WP 4 - FOLLOW UP AND MONITORING OF THE EU CO-
FUNDED PROJECTS
WP 5 - COMMUNICATION AND EXPLOITATION OF RESULTS OF
THE EU CO-FUNDED CALLERA PerMed – cofunding scheme
33% of the budget Unit
commitment 7,834,200 € 1,674,750 € costs
23,740,000 € Maximum EU
9,508,950 € contribution
Initial Financial Commitment
of ERA PerMed Partners
EC cofunded Implementation
call
6,718,613 € 2,790,337 € costsERAPerMed – Content ERA PerMed JTC2018 (co-funded by EC) JTC2019 Next calls: JTC2020 & JTC2021
ERAPerMed – EU co-funded JTC 2018
http://www.erapermed.eu/joint-calls/joint-transnational-call-2018/
19 EU countries
3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
1 third country: Canada
30 Partners
22 Countries 5 regions
Call Secretariat (JCS) Countries´ ex ante Budget
Instituto de Salud Carlos III 26 M €
(ISCIII), SPAIN
Two step procedure
Launch: 14th February 2018
Timeline: Submission deadline for Pre-proposals: 10th April 2018
Submission deadline for invited Full-proposals: 26th July 2018
Expected start of granted projects: 2019 q1Call calendar
Preparation of the JTC2018 Validation of
Survey on the call text by
Expert participation / First draft of CAB response (Pre-) Final version the EC
First concept At least 30 days
consultation advanced concept the call text on the call text of the call text
before launching
April June July August September November December
2017
Final funding decision
JTC2018 in November 2018
Submission Submission
Pre- deadline CSC deadline Rebuttal
Launch PRP meeting
announcement pre-proposals meeting full-proposals phase
December February April June July August September
At least 60 days Evaluation 1st stage Evaluation 2nd stage
2017 2018
Each proposal is allocated to 3 Peer Reviewers for evaluation.ERAPerMed – EU co-funded JTC 2018
Scope of the call
TOPIC: RESEARCH PROJECTS ON PERSONALISED MEDICINE – SMART COMBINATION OF
PRE-CLINICAL AND CLINICAL RESEARCH WITH DATA AND ICT SOLUTIONS
Each project proposal MUST address at least one module of both Research Areas 1 and 2.ERA PerMed JTC 2018
Central Eligibility
A) Academia or research institutes;
B) Clinical/public health sector
C) (Industry) Private partners, e.g. SMEs
• Each consortium must involve at least 3 partners eligible
for funding coming from 3 different countries.
• Project coordinator must be eligible to be funded
• The maximum number of partners per project is 6
(7 if underrepresented)
• No more than two partners from the same country.
• No more than one partner with its own funding is allowed.
* Each FO has its own national/regional eligibility criteriaPartnering Tool https://partnering.pt-dlr.de/ICPerMed
ERAPerMed – EU co-funded JTC 2018 Pre-proposal Coordinators and Partners per Country
ERAPerMed – EU co-funded JTC 2018 Pre-proposal Request of Funding per Country
ERAPerMed – EU co-funded JTC 2018 Type of Applicant Beneficiary Entity in Pre-proposals
ERAPerMed – EU co-funded JTC 2018
ERAPerMed – EU co-funded JTC 2018
Facts and Figures
• Pre-proposal stage:
• 159/143 submitted projects
• 741 partners requesting to 30 funding organisations
• 176.21 M € requested funding
• 50 Pre-proposals invited to submit a Full proposal
• 75 evaluators from institutions affiliated to 24 countries (25% females)
• Full proposal stage:
• 50 submitted projects
• 25 Proposals funded, 131 partners requesting to 21 funding organisations.
• 28.27 M € requested funding
• 23 evaluators from institutions affiliated to 15 countriesERAPerMed – Content ERA PerMed JTC2018 (co-funded by EC) JTC2019 Next calls: JTC2020 & JTC2021
ERAPerMed – non EU co-funded JTC 2019
http://www.erapermed.eu/joint-transnational-call-2019/
17 EU countries
3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
2 third countries: Canada and Egypt
30 Partners 6 regions (Saxony, Quebec, Lombardy,
22 Countries Navarra ,Cataluña and Tuscany
1 charity: AECC
Call Secretariat (JCS)
Agence National de la Recherche (ANR)
FRANCE Countries´ ex ante Budget
31.42 M €
Two step procedure
Launch: 9th January 2019
Submission deadline for Pre-proposals: 7th March 2019
Timeline:
Submission deadline for invited Full-proposals: 17th June 2019ERAPerMed – non EU co-funded JTC 2019
Scope of the call
TOPIC: PERSONALIZED MEDICINE: MULTIDISCIPLINARY RESEARCH
TOWARDS IMPLEMENTATION
Each project proposal MUST address at least one module of
Research Area 3 and at least one module of Research Area 1 or 2.Submitted pre-proposals – N° partners/coordinators
BMBF/DLR 97 22
ANR 86 14
FRRB 39 25
GSRT 43 15
SRC 49 3
IT-MoH 27 23
ISCIII/AECC-FC 33 15
FWF 34 6
DS-CAT 34 4 Partner
UEFISCDI 26 10
Coordinator
AKA 21 13
NCBR 25 3
InnoFond 26 2
no funding request 27 0
CSO-MOH 16 9
RCN 17 3
CIHR 17 2
SMWK 10 7
NKFIH 14 1
GN 11 4
HRB 13 1
TuscReg 10 3
BMG/VDI 11 2
F.R.S.-FNRS 9 2
MSE 8 2
VIAA 7 1
TUBITAK 8 0
FRQS 7 1
FNR 5 1
ASRT 3 2
CDTI 4 0
0 20 40 60 80 100 120Submitted pre-proposals – budget requested
ASRT 567 000,00 €
CDTI 823 802,00 €
TUBITAK 939 300,00 €
MSE 1199 175,00 €
VIAA 1455 347,00 €
FNR 1655 437,00 €
F.R.S.-FNRS 1908 913,00 €
NKFIH 2066 203,00 €
FRQS 2205 592,00 €
TuscReg 2357 042,00 €
GN 3121 934,00 €
BMG/VDI 3401 977,00 €
HRB 3442 102,00 €
CSO-MOH 3588 005,00 €
CIHR 3616 365,00 €
NCBR 4322 676,00 €
RCN 5109 993,00 €
UEFISCDI 5866 548,00 €
SMWK 6624 952,00 €
DS-CAT 7262 921,00 €
AKA 7636 561,00 €
ISCIII/AECC-FC 8608 192,00 €
InnoFond 9168 782,00 €
GSRT 9917 828,00 €
FWF 10384 314,00 €
IT-MoH 11104 420,00 €
SRC 16544 040,00 €
FRRB 18174 737,00 €
ANR 24578 937,00 €
BMBF/DLR 38840 483,00 €
0,00 € 5000 000,00 € 10000 000,00 € 15000 000,00 € 20000 000,00 € 25000 000,00 € 30000 000,00 € 35000 000,00 € 40000 000,00 € 45000 000,00 €ERAPerMed –non EU co-funded JTC 2019
Facts and Figures
• Pre-proposal stage:
• 196 submitted projects
• 906 partners requesting to 30 funding organisations (27 own funding)
• 216 M € requested funding
• 56 Pre-proposals invited to submit a Full proposal
• 102 evaluators from institutions affiliated to 26 countries (33% females)
• Full proposal stage:
• 56 submitted projects
• 22 Proposals expected to be funded, 108 partners requesting to 24
funding organisations (5 partners on own funding).
• 24.6 M € requested funding
• 29 evaluators from institutions affiliated to 17 countriesERAPerMed – Content ERA PerMed JTC2018 (co-funded by EC) JTC2019 Next calls: JTC2020 & JTC2021
ERAPerMed – non EU co-funded JTC 2020
17 EU countries
2 associated countries (to Horizon 2020):
Norway, Israel
3 third countries: Canada, Egypt, Panama
6 regions (Saxony, Quebec, Lombardy,
31 Partners 22 Countries Navarra, Cataluña and Tuscany)
1 charity: AECC
Call Secretariat (JCS)
German Aerospace Center (DLR)
GERMANY permed@dlr.de Countries´ ex ante Budget
24.6 M € approx.
Two step procedure
Launch: December 2019
Timeline expected: Submission deadline for Pre-proposals: March 2020
Submission deadline for invited Full-proposals: June 2020
http://www.erapermed.eu/wp-content/uploads/2019/11/ERA-PerMed_JTC2020_pre-announcement_final.pdfERAPerMed – non EU co-funded JTC 2020
Scope of the call
TOPIC: “PERSONALISED MEDICINE – PRE-/CLINICAL RESEARCH, BIG
DATA AND ICT, IMPLEMENTATION AND USER’S PERSPECTIVE”
Each project proposal MUST address at least one module of
Research Area 3 and at least one module of Research Area 1 or 2.ERAPerMed – Joint Call Secretariat contact points
JCS2018: ISCIII- Mauricio García, Candi Sánchez and Cristina Nieto:
eranetpm@isciii.es
JCS2019: ANR- Monika Frenzel and Jeanne Guihot
ERAPerMed@agencerecherche.fr
JCS2020: DLR- Katja Kuhlmann and Alexandra Becker
permed@dlr.deThank you for your attention!
Contact: Maria Cristina Nieto Garcia, PhD
GRANT AGREEMENT
Horizon 2020
NUMBER — 779282 ERA PerMedYou can also read
